Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia ("CLI") and Acute Myocardial Infarction ("AMI")
RANCHO CORDOVA, Calif., April 10, 2015 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, today announced a corporate update on [...]